MTX-463

N/A

Report date: 2026/03/31 20:00:21
First In Class

Base Information

Drug NameMTX-463
Drug Alias NameMTX-463
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionCCN family member 4 signaling neutralization
TargetsCCN family member 4
Therapy Area/IndicationsFibrosisIdiopathic Pulmonary Fibrosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgiumCanadaUnited States +[12] 
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesMediar Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesMediar Therapeutics IncEli Lilly And Company
Inactive CompaniesN/A
Active IndicationsFibrosisIdiopathic Pulmonary Fibrosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A